Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
VIR | Vir Biotechnology, Inc. | Director | $344K | May 30, 2024 | ||
ADAP | Adaptimmune Therapeutics PLC | Director | Jul 3, 2023 | |||
ALNY | ALNYLAM PHARMACEUTICALS, INC. | Director | May 16, 2024 | |||
SURF | Surface Oncology, Inc. | Director | Sep 8, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|